Investigating hesperetin nanocrystals with tailor-made sizes for the prevention and treatment of Alzheimer's disease.

Stahr, Pascal-L; Grewal, Rekha; Eckert, Gunter P; Keck, Cornelia M

Stahr, Pascal-L; Grewal, Rekha; Eckert, Gunter P; Keck, Cornelia M.

Afiliação

Stahr PL; Department of Pharmaceutics and Biopharmaceutics, Philipps-Universität, Robert-Koch-Str. 4, 35037, Marburg, Germany.
Grewal R; Institute of Nutritional Sciences, Justus-Liebig Universität, Wilhelmstr. 20, 35392, Gießen, Germany.
Eckert GP; Institute of Nutritional Sciences, Justus-Liebig Universität, Wilhelmstr. 20, 35392, Gießen, Germany.
Keck CM; Department of Pharmaceutics and Biopharmaceutics, Philipps-Universität, Robert-Koch-Str. 4, 35037, Marburg, Germany. cornelia.keck@pharmazie.uni-marburg.de.

Drug Deliv Transl Res ; 11(2): 659-674, 2021 04.

Article em En | MEDLINE | ID: mdl-33433841

Assuntos

Doença de Alzheimer; Hesperidina; Nanopartículas; Doença de Alzheimer/tratamento farmacológico; Doença de Alzheimer/prevenção & controle; Humanos; Solubilidade

Palavras-chave

Alzheimer's disease; Antioxidant; Hesperetin; Nanocrystals; Zeta potential

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Doença de Alzheimer / Hesperidina Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google